Search research articles
Contact Us
Filters
Showing results (51-60 of 175) with videos related to
Page
of 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2025
Axicabtagene Ciloleucel in Combination With Atezolizumab in Patients With Refractory Diffuse Large B-cell Lymphoma: The Phase 1/2 ZUMA-6 Trial
Caron A Jacobson, Jason R Westin, David B Miklos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 30, 2016
Cyclin D1 expression in peripheral T-cell lymphomas
Joo Y Song, Liping Song, Alex F Herrera, et al.
The Journal of Molecular Diagnostics : JMD
|
February 26, 2021
Validation of the Double-Hit Gene Expression Signature (DLBCL90) in an Independent Cohort of Patients with Diffuse Large B-Cell Lymphoma of Germinal Center Origin
Ha Nguyen, Anamarija Perry, Pamela Skrabek, et al.
Leukemia & Lymphoma
|
April 17, 2024
Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study
Ibrahim Aldoss, Jianying Zhang, Marjorie Robbins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 9, 2019
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma
Alex F Herrera, Lu Chen, Sirin Khajavian, et al.
Blood Advances
|
June 10, 2022
Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines
Jibin Zhang, Tingting Wang, Kunal Shetty, et al.
Haematologica
|
June 1, 2023
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
Jennifer L Crombie, Caron A Jacobson, Robert Redd, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 15, 2014
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease
Alex F Herrera, Haesook T Kim, Bhavjot Bindra, et al.
Blood Advances
|
November 8, 2021
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data
Laurie H Sehn, Mark Hertzberg, Stephen Opat, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 12, 2021
Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing Analysis
Stephen D Smith, Paolo Lopedote, Yazeed Samara, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 175) with videos related to
Sort By:
Page
of 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2025
Axicabtagene Ciloleucel in Combination With Atezolizumab in Patients With Refractory Diffuse Large B-cell Lymphoma: The Phase 1/2 ZUMA-6 Trial
Caron A Jacobson, Jason R Westin, David B Miklos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 30, 2016
Cyclin D1 expression in peripheral T-cell lymphomas
Joo Y Song, Liping Song, Alex F Herrera, et al.
The Journal of Molecular Diagnostics : JMD
|
February 26, 2021
Validation of the Double-Hit Gene Expression Signature (DLBCL90) in an Independent Cohort of Patients with Diffuse Large B-Cell Lymphoma of Germinal Center Origin
Ha Nguyen, Anamarija Perry, Pamela Skrabek, et al.
Leukemia & Lymphoma
|
April 17, 2024
Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study
Ibrahim Aldoss, Jianying Zhang, Marjorie Robbins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 9, 2019
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma
Alex F Herrera, Lu Chen, Sirin Khajavian, et al.
Blood Advances
|
June 10, 2022
Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines
Jibin Zhang, Tingting Wang, Kunal Shetty, et al.
Haematologica
|
June 1, 2023
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
Jennifer L Crombie, Caron A Jacobson, Robert Redd, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 15, 2014
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease
Alex F Herrera, Haesook T Kim, Bhavjot Bindra, et al.
Blood Advances
|
November 8, 2021
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data
Laurie H Sehn, Mark Hertzberg, Stephen Opat, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 12, 2021
Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing Analysis
Stephen D Smith, Paolo Lopedote, Yazeed Samara, et al.
Page
of 18